iwAL 2018 day 1 discussion: treatment strategies in pediatric and adult ALL
Charles Mullighan et al.
Ibrutinib combined with TGR-1202 in CLL and mantle cell lymphoma (MCL): preliminary results
The explosion of immuno-oncology
Cellular therapy: a key part of EBMT 2017
Reporting positive treatment outcomes with bendamustine + rituximab in indolent lymphomas